{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:56:30Z","timestamp":1789721790949,"version":"4.0.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2025,10,17]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>FLRCC is a rare renal carcinoma subtype caused by FH mutations,\ncategorized into hereditary (germline mutations) and sporadic (somatic mutations) forms. These\nforms are clinically and pathologically similar, complicating differentiation without genetic testing.\nThe aim of this study is to investigate the clinicopathological and molecular genetic differences\nbetween hereditary and sporadic fumarate hydratase (FH)-deficient leiomyomatosis and\nrenal cell carcinoma (FLRCC) to improve diagnostic accuracy and clinical management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method:<\/jats:title>\n                    <jats:p>A retrospective analysis of 14 FLRCC patients was conducted(May 2020-August\n2023). Immunohistochemistry (FH, 2SC, p16), HE staining, and next-generation sequencing\n(NGS) of tumor tissues and blood leukocytes were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The 14 patients with FH-deficient leiomyoma were 25-54 years old, with a mean age of\n36.21 \u00b1 8.16. 78.5% (11\/14) had clinical symptoms and multiple, large-sized fibroids (median\nmaximum volume was 75 mm). Patients with leiomyoma and FH deficiency were divided into\nhereditary and sporadic FLRCC based on FH gene sequencing. Patients with HLRCC had an\nearlier onset, and the serum tumor marker CA125 was more significant. Moreover, tumor tissues\nfrom patients with hereditary and sporadic FH-deficient LRCC differed in immunohistochemical\nand HE staining characteristics, including more positive p16 and greater susceptibility to invasion\nand metastasis in patients with HLRCC, as well as malignant proliferation in patients with\nsporadic FH-deficient LRCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>Although limited by sample size, our preliminary findings indicated subtle differences\nin the age of onset, as well as immunohistochemical and histopathological features of hereditary\nand sporadic FH-deficient LRCC, facilitating the understanding and clinical diagnosis of\nFLRCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In clinical diagnosis, all information should be fully integrated, and a comprehensive\njudgment should be made to make a correct pathological diagnosis and provide targeted\ntreatment for patients with an FH gene mutation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113892010400394250901101048","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:30:16Z","timestamp":1761107416000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinicopathological and Molecular Comparative Analysis of\nHereditary vs. Sporadic Fumarate Hydratase-deficient\nLeiomyomatosis and Renal Carcinoma"],"prefix":"10.2174","volume":"27","author":[{"given":"Qi","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Gynecological Oncology, Tianjin Central Hospital of Obstetrics and Gynecology, Tianjin 300100,China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pairidaguli","family":"Naibijiang","sequence":"additional","affiliation":[{"name":"Department of Gynaecology, Xinjiang Uyghur Autonomous Region Hotan District People's Hospital, HotanDistrict, Xinjiang Uygur Autonomous Region 848000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjing","family":"Hu","sequence":"additional","affiliation":[{"name":"Tianjin Central Hospital of Obstetrics and Gynecology Department of Gynecological Oncology Tianjin China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyue","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tianjin Central Hospital ofObstetrics and Gynecology, Tianjin 300100, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuermaimaiti","family":"Kuyaxikezi","sequence":"additional","affiliation":[{"name":"Department of Gynaecology, Xinjiang Uyghur Autonomous Region Hotan District People's Hospital, HotanDistrict, Xinjiang Uygur Autonomous Region 848000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010400394250901101048","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/246145\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010400394250901101048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:30:22Z","timestamp":1761107422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/246145\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892010400394250901101048","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-03-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}